Milestone Pharmaceuticals: Raymond James cuts target price to $5 from $6
MIST•Raymond James cut its target price for Milestone Pharmaceuticals to $5 from $6.
Related News
Singapore's Genius Group Q3 revenue surges, swings to profit
GNS•
Orion Energy Systems secures automaker contracts worth up to $1.4 million
OESX•
FirstService Residential wins property management contract for Boston's Battery Wharf
FSV•
ABM Respiratory Care secures $20 million financing commitment from Trinity Capital
TRIN•
LiveWire Group showcases expanded product lineup at EICMA
LVWR•